CB vs IMA · P/E 14, rev $59.40B vs rev $9.2M
Chubb Ltd (CB) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CB and IMA stock pages for the full models.
Not investment advice.